What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment

Sven van Egmond*, E (Esther) Baquero Prieto - de Vries, Loes Hollestein, MT (Maarten) Bastiaens, Kees-Peter de Roos, Daniëlle Kuijpers, Ewout Steyerberg, Marlies Wakkee, Klara Mosterd, Tamar Nijsten, E.W. (Esther) de Bekker-Grob

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
7 Downloads (Pure)


Background: Follow-up after low-risk basal cell carcinoma (BCC) is being provided more frequently than recommended by guidelines. To design an acceptable strategy to successfully reduce this 'low-value' care, it is important to obtain insights into the preferences of patients and dermatologists. Objective: To determine the preferences and needs of patients and dermatologists to reduce low-risk BCC follow-up care, and the trade-offs they are willing to make. Methods: A questionnaire including a discrete choice experiment was created, containing attributes regarding amount of follow-up, continuity of care, method of providing addition information, type of healthcare provider, duration of follow-up visits and skin examination. In total, 371 BCC patients and all Dutch dermatologists and dermatology residents (n = 620) were invited to complete the questionnaire. A panel latent class model was used for analysis. Results: Eighty-four dermatologists and 266 BCC patients (21% and 72% response rates respectively) completed the discrete choice experiment. If the post-treatment visit was performed by the same person as treatment provider and a hand-out was provided to patients containing personalised information, the acceptance of having no additional follow-up visits (i.e. following the guidelines) would increase from 55% to 77% by patients. Female patients and older dermatologists, however, are less willing to accept the guidelines and prefer additional follow-up visits. Limitations: The low response rate of dermatologists. Conclusion: This discrete choice experiment revealed a feasible strategy to substantially reduce costs, while maintaining quality of care, based on the preferences and needs of BCC patients, which is supported by dermatologists.

Original languageEnglish
Article numbere0249298
JournalPLoS ONE
Issue number3 March
Publication statusPublished - 29 Mar 2021

Bibliographical note

Funding Information:
This study was sponsored by Citrienfonds (Dutch Ministry of Health, Welfare and Sport) and the health insurance company VGZ (https://www.vgz.nl/). The funders had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the report nor in the decision to submit the article for publication.

Publisher Copyright:
Copyright © 2021 van Egmond et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Dive into the research topics of 'What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment'. Together they form a unique fingerprint.

Cite this